The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Imaging In Clinical Trials Market Research Report 2025
Synopsis
Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.
The global Imaging In Clinical Trials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Imaging In Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Imaging In Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Imaging In Clinical Trials in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Imaging In Clinical Trials include Bioclinica, PAREXEL International Corporation, Intrinsic Imaging, WorldCare Clinical, LLC, ICON plc, KEOSYS Medical Imaging, MEDIAN Technologies, Navitas Life Sciences(TAKE Solutions) and Mint Medical GmbH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Imaging In Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imaging In Clinical Trials.
Report Scope
The Imaging In Clinical Trials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Imaging In Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imaging In Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bioclinica
PAREXEL International Corporation
Intrinsic Imaging
WorldCare Clinical, LLC
ICON plc
KEOSYS Medical Imaging
MEDIAN Technologies
Navitas Life Sciences(TAKE Solutions)
Mint Medical GmbH
Radiant Sage Ventures
Resonance Health
Segment by Type
Services
Software
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Medical Device Manufacturers
Government and Academic Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Imaging In Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.
The global Imaging In Clinical Trials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Imaging In Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Imaging In Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Imaging In Clinical Trials in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Imaging In Clinical Trials include Bioclinica, PAREXEL International Corporation, Intrinsic Imaging, WorldCare Clinical, LLC, ICON plc, KEOSYS Medical Imaging, MEDIAN Technologies, Navitas Life Sciences(TAKE Solutions) and Mint Medical GmbH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Imaging In Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imaging In Clinical Trials.
Report Scope
The Imaging In Clinical Trials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Imaging In Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imaging In Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bioclinica
PAREXEL International Corporation
Intrinsic Imaging
WorldCare Clinical, LLC
ICON plc
KEOSYS Medical Imaging
MEDIAN Technologies
Navitas Life Sciences(TAKE Solutions)
Mint Medical GmbH
Radiant Sage Ventures
Resonance Health
Segment by Type
Services
Software
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Medical Device Manufacturers
Government and Academic Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Imaging In Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Imaging In Clinical Trials Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Services
1.2.3 Software
1.3 Market by Application
1.3.1 Global Imaging In Clinical Trials Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Medical Device Manufacturers
1.3.5 Government and Academic Institutions
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Imaging In Clinical Trials Market Perspective (2019-2030)
2.2 Imaging In Clinical Trials Growth Trends by Region
2.2.1 Global Imaging In Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Imaging In Clinical Trials Historic Market Size by Region (2019-2024)
2.2.3 Imaging In Clinical Trials Forecasted Market Size by Region (2025-2030)
2.3 Imaging In Clinical Trials Market Dynamics
2.3.1 Imaging In Clinical Trials Industry Trends
2.3.2 Imaging In Clinical Trials Market Drivers
2.3.3 Imaging In Clinical Trials Market Challenges
2.3.4 Imaging In Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Imaging In Clinical Trials Players by Revenue
3.1.1 Global Top Imaging In Clinical Trials Players by Revenue (2019-2024)
3.1.2 Global Imaging In Clinical Trials Revenue Market Share by Players (2019-2024)
3.2 Global Imaging In Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Imaging In Clinical Trials Revenue
3.4 Global Imaging In Clinical Trials Market Concentration Ratio
3.4.1 Global Imaging In Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Imaging In Clinical Trials Revenue in 2023
3.5 Imaging In Clinical Trials Key Players Head office and Area Served
3.6 Key Players Imaging In Clinical Trials Product Solution and Service
3.7 Date of Enter into Imaging In Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Imaging In Clinical Trials Breakdown Data by Type
4.1 Global Imaging In Clinical Trials Historic Market Size by Type (2019-2024)
4.2 Global Imaging In Clinical Trials Forecasted Market Size by Type (2025-2030)
5 Imaging In Clinical Trials Breakdown Data by Application
5.1 Global Imaging In Clinical Trials Historic Market Size by Application (2019-2024)
5.2 Global Imaging In Clinical Trials Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Imaging In Clinical Trials Market Size (2019-2030)
6.2 North America Imaging In Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Imaging In Clinical Trials Market Size by Country (2019-2024)
6.4 North America Imaging In Clinical Trials Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Imaging In Clinical Trials Market Size (2019-2030)
7.2 Europe Imaging In Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Imaging In Clinical Trials Market Size by Country (2019-2024)
7.4 Europe Imaging In Clinical Trials Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Imaging In Clinical Trials Market Size (2019-2030)
8.2 Asia-Pacific Imaging In Clinical Trials Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Imaging In Clinical Trials Market Size by Region (2019-2024)
8.4 Asia-Pacific Imaging In Clinical Trials Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Imaging In Clinical Trials Market Size (2019-2030)
9.2 Latin America Imaging In Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Imaging In Clinical Trials Market Size by Country (2019-2024)
9.4 Latin America Imaging In Clinical Trials Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Imaging In Clinical Trials Market Size (2019-2030)
10.2 Middle East & Africa Imaging In Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Imaging In Clinical Trials Market Size by Country (2019-2024)
10.4 Middle East & Africa Imaging In Clinical Trials Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bioclinica
11.1.1 Bioclinica Company Detail
11.1.2 Bioclinica Business Overview
11.1.3 Bioclinica Imaging In Clinical Trials Introduction
11.1.4 Bioclinica Revenue in Imaging In Clinical Trials Business (2019-2024)
11.1.5 Bioclinica Recent Development
11.2 PAREXEL International Corporation
11.2.1 PAREXEL International Corporation Company Detail
11.2.2 PAREXEL International Corporation Business Overview
11.2.3 PAREXEL International Corporation Imaging In Clinical Trials Introduction
11.2.4 PAREXEL International Corporation Revenue in Imaging In Clinical Trials Business (2019-2024)
11.2.5 PAREXEL International Corporation Recent Development
11.3 Intrinsic Imaging
11.3.1 Intrinsic Imaging Company Detail
11.3.2 Intrinsic Imaging Business Overview
11.3.3 Intrinsic Imaging Imaging In Clinical Trials Introduction
11.3.4 Intrinsic Imaging Revenue in Imaging In Clinical Trials Business (2019-2024)
11.3.5 Intrinsic Imaging Recent Development
11.4 WorldCare Clinical, LLC
11.4.1 WorldCare Clinical, LLC Company Detail
11.4.2 WorldCare Clinical, LLC Business Overview
11.4.3 WorldCare Clinical, LLC Imaging In Clinical Trials Introduction
11.4.4 WorldCare Clinical, LLC Revenue in Imaging In Clinical Trials Business (2019-2024)
11.4.5 WorldCare Clinical, LLC Recent Development
11.5 ICON plc
11.5.1 ICON plc Company Detail
11.5.2 ICON plc Business Overview
11.5.3 ICON plc Imaging In Clinical Trials Introduction
11.5.4 ICON plc Revenue in Imaging In Clinical Trials Business (2019-2024)
11.5.5 ICON plc Recent Development
11.6 KEOSYS Medical Imaging
11.6.1 KEOSYS Medical Imaging Company Detail
11.6.2 KEOSYS Medical Imaging Business Overview
11.6.3 KEOSYS Medical Imaging Imaging In Clinical Trials Introduction
11.6.4 KEOSYS Medical Imaging Revenue in Imaging In Clinical Trials Business (2019-2024)
11.6.5 KEOSYS Medical Imaging Recent Development
11.7 MEDIAN Technologies
11.7.1 MEDIAN Technologies Company Detail
11.7.2 MEDIAN Technologies Business Overview
11.7.3 MEDIAN Technologies Imaging In Clinical Trials Introduction
11.7.4 MEDIAN Technologies Revenue in Imaging In Clinical Trials Business (2019-2024)
11.7.5 MEDIAN Technologies Recent Development
11.8 Navitas Life Sciences(TAKE Solutions)
11.8.1 Navitas Life Sciences(TAKE Solutions) Company Detail
11.8.2 Navitas Life Sciences(TAKE Solutions) Business Overview
11.8.3 Navitas Life Sciences(TAKE Solutions) Imaging In Clinical Trials Introduction
11.8.4 Navitas Life Sciences(TAKE Solutions) Revenue in Imaging In Clinical Trials Business (2019-2024)
11.8.5 Navitas Life Sciences(TAKE Solutions) Recent Development
11.9 Mint Medical GmbH
11.9.1 Mint Medical GmbH Company Detail
11.9.2 Mint Medical GmbH Business Overview
11.9.3 Mint Medical GmbH Imaging In Clinical Trials Introduction
11.9.4 Mint Medical GmbH Revenue in Imaging In Clinical Trials Business (2019-2024)
11.9.5 Mint Medical GmbH Recent Development
11.10 Radiant Sage Ventures
11.10.1 Radiant Sage Ventures Company Detail
11.10.2 Radiant Sage Ventures Business Overview
11.10.3 Radiant Sage Ventures Imaging In Clinical Trials Introduction
11.10.4 Radiant Sage Ventures Revenue in Imaging In Clinical Trials Business (2019-2024)
11.10.5 Radiant Sage Ventures Recent Development
11.11 Resonance Health
11.11.1 Resonance Health Company Detail
11.11.2 Resonance Health Business Overview
11.11.3 Resonance Health Imaging In Clinical Trials Introduction
11.11.4 Resonance Health Revenue in Imaging In Clinical Trials Business (2019-2024)
11.11.5 Resonance Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Imaging In Clinical Trials Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Services
Table 3. Key Players of Software
Table 4. Global Imaging In Clinical Trials Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Imaging In Clinical Trials Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Imaging In Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Imaging In Clinical Trials Market Share by Region (2019-2024)
Table 8. Global Imaging In Clinical Trials Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Imaging In Clinical Trials Market Share by Region (2025-2030)
Table 10. Imaging In Clinical Trials Market Trends
Table 11. Imaging In Clinical Trials Market Drivers
Table 12. Imaging In Clinical Trials Market Challenges
Table 13. Imaging In Clinical Trials Market Restraints
Table 14. Global Imaging In Clinical Trials Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Imaging In Clinical Trials Market Share by Players (2019-2024)
Table 16. Global Top Imaging In Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imaging In Clinical Trials as of 2023)
Table 17. Ranking of Global Top Imaging In Clinical Trials Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Imaging In Clinical Trials Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Imaging In Clinical Trials Product Solution and Service
Table 21. Date of Enter into Imaging In Clinical Trials Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Imaging In Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Imaging In Clinical Trials Revenue Market Share by Type (2019-2024)
Table 25. Global Imaging In Clinical Trials Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Imaging In Clinical Trials Revenue Market Share by Type (2025-2030)
Table 27. Global Imaging In Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Imaging In Clinical Trials Revenue Market Share by Application (2019-2024)
Table 29. Global Imaging In Clinical Trials Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Imaging In Clinical Trials Revenue Market Share by Application (2025-2030)
Table 31. North America Imaging In Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Imaging In Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Imaging In Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Imaging In Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Imaging In Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Imaging In Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Imaging In Clinical Trials Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Imaging In Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Imaging In Clinical Trials Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Imaging In Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Imaging In Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Imaging In Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Imaging In Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Imaging In Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Imaging In Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bioclinica Company Detail
Table 47. Bioclinica Business Overview
Table 48. Bioclinica Imaging In Clinical Trials Product
Table 49. Bioclinica Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 50. Bioclinica Recent Development
Table 51. PAREXEL International Corporation Company Detail
Table 52. PAREXEL International Corporation Business Overview
Table 53. PAREXEL International Corporation Imaging In Clinical Trials Product
Table 54. PAREXEL International Corporation Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 55. PAREXEL International Corporation Recent Development
Table 56. Intrinsic Imaging Company Detail
Table 57. Intrinsic Imaging Business Overview
Table 58. Intrinsic Imaging Imaging In Clinical Trials Product
Table 59. Intrinsic Imaging Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 60. Intrinsic Imaging Recent Development
Table 61. WorldCare Clinical, LLC Company Detail
Table 62. WorldCare Clinical, LLC Business Overview
Table 63. WorldCare Clinical, LLC Imaging In Clinical Trials Product
Table 64. WorldCare Clinical, LLC Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 65. WorldCare Clinical, LLC Recent Development
Table 66. ICON plc Company Detail
Table 67. ICON plc Business Overview
Table 68. ICON plc Imaging In Clinical Trials Product
Table 69. ICON plc Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 70. ICON plc Recent Development
Table 71. KEOSYS Medical Imaging Company Detail
Table 72. KEOSYS Medical Imaging Business Overview
Table 73. KEOSYS Medical Imaging Imaging In Clinical Trials Product
Table 74. KEOSYS Medical Imaging Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 75. KEOSYS Medical Imaging Recent Development
Table 76. MEDIAN Technologies Company Detail
Table 77. MEDIAN Technologies Business Overview
Table 78. MEDIAN Technologies Imaging In Clinical Trials Product
Table 79. MEDIAN Technologies Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 80. MEDIAN Technologies Recent Development
Table 81. Navitas Life Sciences(TAKE Solutions) Company Detail
Table 82. Navitas Life Sciences(TAKE Solutions) Business Overview
Table 83. Navitas Life Sciences(TAKE Solutions) Imaging In Clinical Trials Product
Table 84. Navitas Life Sciences(TAKE Solutions) Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 85. Navitas Life Sciences(TAKE Solutions) Recent Development
Table 86. Mint Medical GmbH Company Detail
Table 87. Mint Medical GmbH Business Overview
Table 88. Mint Medical GmbH Imaging In Clinical Trials Product
Table 89. Mint Medical GmbH Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 90. Mint Medical GmbH Recent Development
Table 91. Radiant Sage Ventures Company Detail
Table 92. Radiant Sage Ventures Business Overview
Table 93. Radiant Sage Ventures Imaging In Clinical Trials Product
Table 94. Radiant Sage Ventures Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 95. Radiant Sage Ventures Recent Development
Table 96. Resonance Health Company Detail
Table 97. Resonance Health Business Overview
Table 98. Resonance Health Imaging In Clinical Trials Product
Table 99. Resonance Health Revenue in Imaging In Clinical Trials Business (2019-2024) & (US$ Million)
Table 100. Resonance Health Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Imaging In Clinical Trials Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Imaging In Clinical Trials Market Share by Type: 2023 VS 2030
Figure 3. Services Features
Figure 4. Software Features
Figure 5. Global Imaging In Clinical Trials Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Imaging In Clinical Trials Market Share by Application: 2023 VS 2030
Figure 7. Biotechnology Companies Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Medical Device Manufacturers Case Studies
Figure 10. Government and Academic Institutions Case Studies
Figure 11. Others Case Studies
Figure 12. Imaging In Clinical Trials Report Years Considered
Figure 13. Global Imaging In Clinical Trials Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Imaging In Clinical Trials Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Imaging In Clinical Trials Market Share by Region: 2023 VS 2030
Figure 16. Global Imaging In Clinical Trials Market Share by Players in 2023
Figure 17. Global Top Imaging In Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imaging In Clinical Trials as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Imaging In Clinical Trials Revenue in 2023
Figure 19. North America Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Imaging In Clinical Trials Market Share by Country (2019-2030)
Figure 21. United States Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Imaging In Clinical Trials Market Share by Country (2019-2030)
Figure 25. Germany Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Imaging In Clinical Trials Market Share by Region (2019-2030)
Figure 33. China Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Imaging In Clinical Trials Market Share by Country (2019-2030)
Figure 41. Mexico Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Imaging In Clinical Trials Market Share by Country (2019-2030)
Figure 45. Turkey Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Imaging In Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Bioclinica Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 48. PAREXEL International Corporation Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 49. Intrinsic Imaging Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 50. WorldCare Clinical, LLC Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 51. ICON plc Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 52. KEOSYS Medical Imaging Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 53. MEDIAN Technologies Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 54. Navitas Life Sciences(TAKE Solutions) Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 55. Mint Medical GmbH Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 56. Radiant Sage Ventures Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 57. Resonance Health Revenue Growth Rate in Imaging In Clinical Trials Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
